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The ability to control the functional outcome of the 
genome is necessary for biological research, disease 
diagnosis and treatment. As cells generally use 
complex networks with dynamic interactions between 
many genes, we focus on developing novel synthetic 
biology technologies that enable perturbation and 
study of such networks. Here I will present methods 
(e.g., CRISPRi) repurposed from the bacterial adaptive 
immune CRISPR system, as a set of diverse genetic 
tools for multiplexed, reversible, sequence-specific 
gene regulation. We show these tools are universal, 
which can perform efficient and robust control of gene 
expression in diverse organisms spanning from 
bacteria to yeast to mammalian cells. We expand an 
orthogonal dCas9-based platform that enables 
paralleled transcriptome manipulation. We 
demonstrate that the CRISPRi-mediated gene 
regulation is suitable for genetic screens, allowing 
large-scale interrogation of individual or combinatorial 
genes with important phenotypes including cell growth, 
drug resistance and cellular differentiation. For 
applications, we further develop the non-editing based 
genome engineering approaches that allow one to mediate metabolic pathways, rapidly identify drug resistance 
gene targets, and potentially enable diagnosis and therapeutics. 
 
  
Figure 1 – A platform based on CRISPR system for 
sequence-specific gene regulation and applications 
in diverse organisms. 
